Medication Abortion

Improved access to abortion care during the COVID-19 pandemic through implementation of a no-test protocol for medication abortion, use of Lactin-V in treatment of recurrent bacterial vaginosis, importance of expanded access to postpartum contraceptive options to improve both maternal and fetal outcomes, and more.

The ACOG Committee Opinion’s stance on telehealth, an analysis of the safety and efficacy of self-administered vs. provider-administered medication abortion, influential factors in postpartum contraception use and short inter pregnancy intervals, and more.

What providers need to know about telehealth options for birth control, STI, abortion, and more.

What the research shows about telehealth’s safety, acceptability, and ability to improve access to sexual and reproductive health care services.

The importance of patient-centered contraceptive counseling, expedited scheduling of interval tubal ligation as a way to improve access to sterilization, a study of barriers to IUD access for adolescent patients, and more.

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

The CDC’s yearly STD report, potential for a trivalent vaccine for genital herpes in the future, hormonal contraceptive use among women with opioid use disorder, improved patient bleeding patters with correct fundal placement of IUDs, and more.

An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.